Integrated Cannabis Company, Inc. Signs Definitive Agreement with Empower Clinics Inc. and Receives Purchase Order

VANCOUVER, British Columbia , Nov. 07, 2018 (GLOBE NEWSWIRE) — Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis”), is pleased to announce the completion of a Definitive Agreement (“the Agreement”) to distribute X-SPRAYS™ products throughout the clinics and doctors’ offices of Empower Clinics Inc. (CSE: EPW; FRA: 8EC) (“Empower”), a leading owner and operator of medical cannabis and wellness clinics in the United States (US).

Integrated Cannabis has also received its initial purchase order from Empower for a selection of X-SPRAYS™ products. Empower has more than 25,000 patients under care across 15 locations with medical cannabis treatments in Oregon, Washington and Illinois. The patient base in Oregon represents approximately one-third of the state’s total medical card issuance. In addition, Empower has an historical patient database of which exceeds 120,000 in the three States.

“This milestone marks another significant move for distribution of X-SPRAYS™ with its first shipment to the Chicago market. We are excited to align with Empower and the City of Chicago and have our products available for people visiting their clinics in search of relief with issues like opioid addiction, pain, anxiety, sleep issues and people seeking overall well-being,” said Mr. John Knapp, CEO of Integrated Cannabis.

“We love the X-SPRAYS™ products and look forward to expanding our suite of offerings through these innovative CBD sprays. X-SPRAYS™ state of the art formulations and unique metered dosage combine to consistently deliver a high quality product through our nationwide network of clinics,” said Mr. Craig Snyder, CEO of Empower.

On September 12, Empower announced the opening of its flagship Chicago clinic. In Illinois, the company seeks to expand its operations and achieve a leadership position as it executes on parallel national clinic and product strategies. There is currently an opioid epidemic in the United States and the company’s announced Chicago facility closely followed the endorsement by Illinois Governor Bruce Rauner of medical cannabis as a frontline treatment and alternative for patients with a new statewide measure he signed into law on Aug 28.

ABOUT INTEGRATED CANNABIS COMPANY
Integrated Cannabis Company, Inc. is comprised of dedicated scientists and product engineers who are passionate about health and creating health and lifestyle products utilizing advanced delivery systems and formulations. For more information, please visit the company’s website at: www.x-sprays.com.

ABOUT EMPOWER
Empower is a leading owner and operator of medical cannabis and wellness clinics, as well as a developer of medical products in the US, focused on enabling individuals to improve and protect their health. The company provides treatment solutions through its physician-staffed clinics that are focused on education, data, and efficacy. Empower is a recognized leader and the first choice for patients seeking quality experience and improved health.

ON BEHALF OF THE BOARD

“John Knapp”

Chief Executive Officer

For further information, please contact the Company at: 
Telephone: 778-403-3358
Email: integratedcannabis@gmail.com

The CSE does not accept responsibility for the adequacy or accuracy of this release. 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.